SecBot SecBot
8-K ·Filed Nov 6, 2026

RLYB

Rallybio Corp
BEARISH
Impact 6/10
Processed5h 35m ago SEC0001193125-26-452115
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-452115
Document: 0001193125-26-452115-index-headers.html0001193125-26-452115
Document: 0001193125-26-452115-index.html0001193125-26-452115
Document: 0001193125-26-452115.txt0001193125-26-452115
11 reports for RLYB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RLYB, sortable and filterable
TypeNow
Nov 6, 2026
today
425
BEARISH ★ 7/10
$15.73awaiting T+60awaiting T+60$15.75 (−0.13%)
Nov 6, 2026
today
8-K
BEARISH ★ 6/10
$15.73awaiting T+60awaiting T+60$15.75 (−0.13%)
Nov 4, 2026
2d ago
8-K
NEUTRAL ★ 5/10
$15.69awaiting T+60awaiting T+60$15.75 (+0.38%)
Oct 26, 2026
11d ago
425
NEUTRAL ★ 5/10
$15.93awaiting T+60awaiting T+60$15.75 (−1.13%)
Oct 26, 2026
11d ago
8-K
NEUTRAL ★ 5/10
$15.93awaiting T+60awaiting T+60$15.75 (−1.13%)
Oct 16, 2026
21d ago
EFFECT
NEUTRAL ★ 4/10
$16.28awaiting T+60awaiting T+60$15.75 (−3.26%)
Oct 14, 2026
23d ago
S-4/A
NEUTRAL ★ 6/10
$16.78awaiting T+60awaiting T+60$15.75 (−6.11%)
Jul 15, 2026
16w ago
S-4
NEUTRAL ★ 6/10
$15.96 $17.02▲ +6.64%▲ +2.93%$15.75 (−1.32%)
Jun 1, 2026
22w ago
425
BULLISH ★ 7/10
$16.87 $16.89▲ +0.09%▼ −1.14%$15.75 (−6.64%)
Jun 1, 2026
22w ago
8-K
BULLISH ★ 7/10
$16.87 $16.89▲ +0.09%▼ −1.14%$15.75 (−6.64%)
Showing 10 of 11

US Market Status

Market Closed · Opens Mon (34h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026

Fresh RLYB Intelligence

Analysis is for subscribers only.

Subscribe for Full Access